1995 ◽  
Vol 175 (4) ◽  
pp. 415-420 ◽  
Author(s):  
W. A. H. Wallace ◽  
S. E. M. Howie ◽  
D. Lamb ◽  
D. M. Salter

1981 ◽  
Vol 60 (3) ◽  
pp. 261-265
Author(s):  
R. M. Topping ◽  
A. H. Craven ◽  
Susan Whiting ◽  
B. G. Rigden ◽  
M. Turner-Warwick ◽  
...  

1. Proteinase inhibitors have been studied in whole serum by using a kinetic method that avoids potentially damaging protein separation procedures. 2. The α2-macroglobulin of an individual can be allocated unambiguously into one of seven categories according to the binding of trypsin to inhibitor in two kinetically apparent binding modes (β- and α-modes). 3. The distribution of α2-macroglobulin β:α ratios in a healthy adult population is defined, and shown to be independent of sex and age. 4. The distribution of β: α ratios in a group of patients with cryptogenic fibrosing alveolitis was found to be significantly different (P < 0.005) from the normal distribution. 5. Changes in the β: α ratio were noted in five of six patients with cryptogenic fibrosing alveolitis after treatment, but on no occasion when two healthy subjects were assessed a total of nine times. 6. The molecular interpretation and the possible importance of altered proteinase inhibition in inflammation and fibrosis are discussed.


1998 ◽  
Vol 157 (3) ◽  
pp. 743-747 ◽  
Author(s):  
RICHARD HUBBARD ◽  
ANDREA VENN ◽  
CHRIS SMITH ◽  
MARIE COOPER ◽  
IAN JOHNSTON ◽  
...  

Author(s):  
Gavin P Spickett

Cardiac disease 1: myocarditis and cardiomyopathy Cardiac disease 2: eosinophilic syndromes Cardiac disease 3: recurrent pericarditis and Dressler’s syndrome Cardiac disease 4: rheumatic fever Respiratory disease 1: idiopathic pulmonary fibrosis (cryptogenic fibrosing alveolitis) Respiratory disease 2: pulmonary alveolar proteinosis (PAP) Respiratory disease 3: lymphoid interstitial pneumonitis and sarcoidosis...


Sign in / Sign up

Export Citation Format

Share Document